Ligand source activities (1 row/activity)
Ligands (move mouse cursor over ligand name to see structure) | Receptor | Activity | Chemical information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
|
Ligands (move mouse cursor over ligand name to see structure)
| Receptor
| Activity
| Chemical information
| |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
| |
16139605 | 3772 | None | 14 | Human | Functional | pEC50 | = | 11 | 11.0 | 4 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | None | nan | ||||
16139605.0 | 3772 | None | 14 | Human | Functional | pEC50 | = | 11 | 11.0 | 4 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | None | nan | ||||
4718 | 3772 | None | 14 | Human | Functional | pEC50 | = | 11 | 11.0 | 4 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | None | nan | ||||
7049 | 3772 | None | 14 | Human | Functional | pEC50 | = | 11 | 11.0 | 4 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | None | nan | ||||
70683012 | 3772 | None | 14 | Human | Functional | pEC50 | = | 11 | 11.0 | 4 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | None | nan | ||||
CHEMBL2104987 | 3772 | None | 14 | Human | Functional | pEC50 | = | 11 | 11.0 | 4 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | None | nan | ||||
DB08900 | 3772 | None | 14 | Human | Functional | pEC50 | = | 11 | 11.0 | 4 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | None | nan | ||||
CHEMBL4290380 | 215955 | None | 0 | Human | Functional | pEC50 | = | 10.7 | 10.7 | 3890 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC | nan | ||||
1140 | 1821 | None | 25 | Human | Functional | pEC50 | = | 10.2 | 10.2 | 2754 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | None | nan | ||||
155817393 | 1821 | None | 25 | Human | Functional | pEC50 | = | 10.2 | 10.2 | 2754 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | None | nan | ||||
71300624 | 1821 | None | 25 | Human | Functional | pEC50 | = | 10.2 | 10.2 | 2754 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | None | nan | ||||
90488755 | 1821 | None | 25 | Human | Functional | pEC50 | = | 10.2 | 10.2 | 2754 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | None | nan | ||||
91928512 | 1821 | None | 25 | Human | Functional | pEC50 | = | 10.2 | 10.2 | 2754 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | None | nan | ||||
CHEMBL2177395 | 1821 | None | 25 | Human | Functional | pEC50 | = | 10.2 | 10.2 | 2754 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | None | nan | ||||
CHEMBL4283827 | 215903 | None | 0 | Human | Functional | pEC50 | = | 10.2 | 10.2 | 416 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC | nan | ||||
CHEMBL4289348 | 215946 | None | 0 | Human | Functional | pEC50 | = | 10.2 | 10.2 | -1 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC | nan | ||||
155547905 | 173742 | None | 0 | Human | Functional | pEC50 | = | 10.1 | 10.1 | -1 | 2 | Agonist activity at human GLP-2 receptor expressed in CHO-K1 cells assessed as cAMP induction by FRET assayAgonist activity at human GLP-2 receptor expressed in CHO-K1 cells assessed as cAMP induction by FRET assay |
ChEMBL | 3654 | 118 | 54 | 51 | -15.0 | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC | 10.1021/acs.jmedchem.9b00835 | ||
CHEMBL4534113 | 173742 | None | 0 | Human | Functional | pEC50 | = | 10.1 | 10.1 | -1 | 2 | Agonist activity at human GLP-2 receptor expressed in CHO-K1 cells assessed as cAMP induction by FRET assayAgonist activity at human GLP-2 receptor expressed in CHO-K1 cells assessed as cAMP induction by FRET assay |
ChEMBL | 3654 | 118 | 54 | 51 | -15.0 | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC | 10.1021/acs.jmedchem.9b00835 | ||
CHEMBL4280632 | 215869 | None | 0 | Human | Functional | pEC50 | = | 10 | 10.0 | 177 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC | nan | ||||
CHEMBL4288739 | 215942 | None | 0 | Human | Functional | pEC50 | = | 9.9 | 9.9 | 363 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)C(C)(C)N)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC | nan | ||||
CHEMBL4284169 | 215905 | None | 0 | Human | Functional | pEC50 | = | 9.7 | 9.7 | 3 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC | nan | ||||
CHEMBL4285251 | 215915 | None | 0 | Human | Functional | pEC50 | = | 9.7 | 9.7 | 5 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC | nan | ||||
CHEMBL4288233 | 215937 | None | 0 | Human | Functional | pEC50 | = | 9.7 | 9.7 | 45 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC | nan | ||||
CHEMBL4290760 | 215963 | None | 0 | Human | Functional | pEC50 | = | 9.7 | 9.7 | 5 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC | nan | ||||
CHEMBL4294238 | 215990 | None | 0 | Human | Functional | pEC50 | = | 9.7 | 9.7 | 1 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC | nan | ||||
155560523 | 175172 | None | 0 | Human | Functional | pEC50 | = | 9 | 9.0 | -5 | 2 | Agonist activity at human GLP-2 receptor expressed in CHO-K1 cells assessed as cAMP induction by FRET assayAgonist activity at human GLP-2 receptor expressed in CHO-K1 cells assessed as cAMP induction by FRET assay |
ChEMBL | 3907 | 135 | 55 | 52 | -10.3 | CCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC | 10.1021/acs.jmedchem.9b00835 | ||
CHEMBL4568184 | 175172 | None | 0 | Human | Functional | pEC50 | = | 9 | 9.0 | -5 | 2 | Agonist activity at human GLP-2 receptor expressed in CHO-K1 cells assessed as cAMP induction by FRET assayAgonist activity at human GLP-2 receptor expressed in CHO-K1 cells assessed as cAMP induction by FRET assay |
ChEMBL | 3907 | 135 | 55 | 52 | -10.3 | CCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC | 10.1021/acs.jmedchem.9b00835 | ||
CHEMBL4276728 | 215826 | None | 0 | Human | Functional | pEC50 | = | 8.4 | 8.4 | -128 | 2 | Agonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assayAgonist activity at human GLP2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation by AlphaScreen assay |
ChEMBL | None | None | None | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)C(C)(C)N)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC | nan | ||||
16139605 | 3772 | None | 14 | Human | Functional | pEC50 | = | 8 | 8.0 | 4 | 2 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
16139605.0 | 3772 | None | 14 | Human | Functional | pEC50 | = | 8 | 8.0 | 4 | 2 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
4718 | 3772 | None | 14 | Human | Functional | pEC50 | = | 8 | 8.0 | 4 | 2 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
7049 | 3772 | None | 14 | Human | Functional | pEC50 | = | 8 | 8.0 | 4 | 2 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
70683012 | 3772 | None | 14 | Human | Functional | pEC50 | = | 8 | 8.0 | 4 | 2 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
CHEMBL2104987 | 3772 | None | 14 | Human | Functional | pEC50 | = | 8 | 8.0 | 4 | 2 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
DB08900 | 3772 | None | 14 | Human | Functional | pEC50 | = | 8 | 8.0 | 4 | 2 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
16139605 | 3772 | None | 14 | Rat | Functional | pEC50 | = | 8 | 8.0 | -4 | 2 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
16139605.0 | 3772 | None | 14 | Rat | Functional | pEC50 | = | 8 | 8.0 | -4 | 2 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
4718 | 3772 | None | 14 | Rat | Functional | pEC50 | = | 8 | 8.0 | -4 | 2 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
7049 | 3772 | None | 14 | Rat | Functional | pEC50 | = | 8 | 8.0 | -4 | 2 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
70683012 | 3772 | None | 14 | Rat | Functional | pEC50 | = | 8 | 8.0 | -4 | 2 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
CHEMBL2104987 | 3772 | None | 14 | Rat | Functional | pEC50 | = | 8 | 8.0 | -4 | 2 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
DB08900 | 3772 | None | 14 | Rat | Functional | pEC50 | = | 8 | 8.0 | -4 | 2 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
Drug Central | None | None | None | None | None | ||||
9896 | 1811 | None | 0 | Human | Functional | pEC50 | = | 10.6 | 10.6 | - | 1 | Determined in a reporter assay using HEK293 cells stably overexpressing a cAMP response element (CRE) driven luciferase reporter and human GLP-2R.Determined in a reporter assay using HEK293 cells stably overexpressing a cAMP response element (CRE) driven luciferase reporter and human GLP-2R. |
Guide to Pharmacology | None | None | None | None | 29528634 | ||||
10685 | 447 | None | 0 | Human | Functional | pEC50 | = | 10.5 | 10.5 | - | 1 | UnclassifiedUnclassified |
Guide to Pharmacology | None | None | None | None | 30614011 | ||||
10685 | 447 | None | 0 | Human | Functional | pEC50 | = | 10.5 | 10.5 | - | 1 | UnclassifiedUnclassified |
Guide to Pharmacology | None | None | None | None | 32075870 | ||||
1140 | 1821 | None | 25 | Human | Functional | pIC50 | = | 8.5 | 8.5 | 2754 | 2 | UnclassifiedUnclassified |
Guide to Pharmacology | None | None | None | None | 11738243 | ||||
155817393 | 1821 | None | 25 | Human | Functional | pIC50 | = | 8.5 | 8.5 | 2754 | 2 | UnclassifiedUnclassified |
Guide to Pharmacology | None | None | None | None | 11738243 | ||||
71300624 | 1821 | None | 25 | Human | Functional | pIC50 | = | 8.5 | 8.5 | 2754 | 2 | UnclassifiedUnclassified |
Guide to Pharmacology | None | None | None | None | 11738243 | ||||
90488755 | 1821 | None | 25 | Human | Functional | pIC50 | = | 8.5 | 8.5 | 2754 | 2 | UnclassifiedUnclassified |
Guide to Pharmacology | None | None | None | None | 11738243 | ||||
91928512 | 1821 | None | 25 | Human | Functional | pIC50 | = | 8.5 | 8.5 | 2754 | 2 | UnclassifiedUnclassified |
Guide to Pharmacology | None | None | None | None | 11738243 |
Showing 1 to 50 of 55 entries
Ligands (move mouse cursor over ligand name to see structure) | Receptor | Activity | Chemical information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
|
Ligands (move mouse cursor over ligand name to see structure)
| Receptor
| Activity
| Chemical information
| |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
| |
127050829 | 141033 | None | 0 | Human | Binding | pEC50 | = | 10.5 | 10.5 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 4081 | 143 | 55 | 56 | -13.4 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3822928 | 141033 | None | 0 | Human | Binding | pEC50 | = | 10.5 | 10.5 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 4081 | 143 | 55 | 56 | -13.4 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127049562 | 141052 | None | 0 | Human | Binding | pEC50 | = | 10.5 | 10.5 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3764 | 125 | 53 | 50 | -11.9 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3823133 | 141052 | None | 0 | Human | Binding | pEC50 | = | 10.5 | 10.5 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3764 | 125 | 53 | 50 | -11.9 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127050816 | 141083 | None | 0 | Human | Binding | pEC50 | = | 10.5 | 10.5 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3763 | 125 | 53 | 50 | -12.5 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3823541 | 141083 | None | 0 | Human | Binding | pEC50 | = | 10.5 | 10.5 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3763 | 125 | 53 | 50 | -12.5 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127052645 | 141118 | None | 0 | Human | Binding | pEC50 | = | 10.5 | 10.5 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 4010 | 140 | 54 | 55 | -12.9 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCCOCCOCCOCCOCCC(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3823976 | 141118 | None | 0 | Human | Binding | pEC50 | = | 10.5 | 10.5 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 4010 | 140 | 54 | 55 | -12.9 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCCOCCOCCOCCOCCC(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127051717 | 141025 | None | 0 | Human | Binding | pEC50 | = | 10.4 | 10.4 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3854 | 127 | 53 | 51 | -11.3 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCc1ccncc1)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3822792 | 141025 | None | 0 | Human | Binding | pEC50 | = | 10.4 | 10.4 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3854 | 127 | 53 | 51 | -11.3 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCc1ccncc1)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127052654 | 141107 | None | 0 | Human | Binding | pEC50 | = | 10.4 | 10.4 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3464 | 115 | 49 | 46 | -11.5 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3823835 | 141107 | None | 0 | Human | Binding | pEC50 | = | 10.4 | 10.4 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3464 | 115 | 49 | 46 | -11.5 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127050816 | 141083 | None | 0 | Rat | Binding | pEC50 | = | 10.4 | 10.4 | - | 0 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3763 | 125 | 53 | 50 | -12.5 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3823541 | 141083 | None | 0 | Rat | Binding | pEC50 | = | 10.4 | 10.4 | - | 0 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3763 | 125 | 53 | 50 | -12.5 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127051083 | 141063 | None | 0 | Human | Binding | pEC50 | = | 10.3 | 10.3 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3791 | 126 | 53 | 50 | -11.9 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3823327 | 141063 | None | 0 | Human | Binding | pEC50 | = | 10.3 | 10.3 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3791 | 126 | 53 | 50 | -11.9 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127048586 | 141109 | None | 0 | Human | Binding | pEC50 | = | 10.3 | 10.3 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3799 | 126 | 54 | 52 | -13.1 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1cccs1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3823847 | 141109 | None | 0 | Human | Binding | pEC50 | = | 10.3 | 10.3 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3799 | 126 | 54 | 52 | -13.1 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1cccs1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127051089 | 141003 | None | 0 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3798 | 125 | 53 | 50 | -11.7 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3822459 | 141003 | None | 0 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3798 | 125 | 53 | 50 | -11.7 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127048573 | 141119 | None | 0 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3819 | 127 | 53 | 50 | -11.2 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3823985 | 141119 | None | 0 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3819 | 127 | 53 | 50 | -11.2 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127051393 | 141135 | None | 0 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3797 | 125 | 53 | 50 | -12.3 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3824232 | 141135 | None | 0 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3797 | 125 | 53 | 50 | -12.3 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
1140 | 1821 | None | 25 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 1 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 | ||||
155817393 | 1821 | None | 25 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 1 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 | ||||
71300624 | 1821 | None | 25 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 1 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 | ||||
90488755 | 1821 | None | 25 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 1 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 | ||||
91928512 | 1821 | None | 25 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 1 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 | ||||
CHEMBL2177395 | 1821 | None | 25 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 1 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 | ||||
127052351 | 141067 | None | 0 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3490 | 114 | 49 | 47 | -10.9 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1cccs1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3823334 | 141067 | None | 0 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3490 | 114 | 49 | 47 | -10.9 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1cccs1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127051091 | 141075 | None | 0 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3484 | 114 | 49 | 46 | -11.0 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3823421 | 141075 | None | 0 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3484 | 114 | 49 | 46 | -11.0 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127049891 | 141127 | None | 0 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3803 | 125 | 53 | 51 | -12.3 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1cccs1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3824079 | 141127 | None | 0 | Human | Binding | pEC50 | = | 10.2 | 10.2 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3803 | 125 | 53 | 51 | -12.3 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1cccs1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127049246 | 141032 | None | 0 | Human | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3434 | 114 | 48 | 45 | -10.9 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3822888 | 141032 | None | 0 | Human | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3434 | 114 | 48 | 45 | -10.9 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127052936 | 141061 | None | 0 | Human | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3474 | 114 | 48 | 46 | -10.6 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1cccs1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3823291 | 141061 | None | 0 | Human | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3474 | 114 | 48 | 46 | -10.6 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1cccs1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
127051718 | 141136 | None | 0 | Human | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3440 | 114 | 48 | 46 | -10.8 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1cccs1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
CHEMBL3824241 | 141136 | None | 0 | Human | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | 3440 | 114 | 48 | 46 | -10.8 | CCCCC(NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1cccs1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O | 10.1021/acs.jmedchem.5b01909 | ||
16139605 | 3772 | None | 14 | Rat | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 | ||||
16139605.0 | 3772 | None | 14 | Rat | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 | ||||
4718 | 3772 | None | 14 | Rat | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 | ||||
7049 | 3772 | None | 14 | Rat | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 | ||||
70683012 | 3772 | None | 14 | Rat | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 | ||||
CHEMBL2104987 | 3772 | None | 14 | Rat | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 | ||||
DB08900 | 3772 | None | 14 | Rat | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 | ||||
16139605 | 3772 | None | 14 | Human | Binding | pEC50 | = | 10.1 | 10.1 | - | 0 | Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assayAgonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay |
ChEMBL | None | None | None | None | 10.1021/acs.jmedchem.5b01909 |
Showing 1 to 50 of 204 entries